Navigation Links
Simple brain mechanisms explain arbitrary human visual decisions
Date:11/9/2008

asked to indicate which type of image they believed they had seen by either moving their eyes in a particular direction if they had seen a face or pointing their hand in the same direction if they had seen a building.

"This decision is not automatic," Corbetta says. "It requires both attention to the stimuli and control of the response."

Researchers took functional magnetic resonance imaging scans of subjects' brains as they performed the task. The scans were conducted at the Institute of Technology and Advanced Bio-imaging in Chieti as a collaboration between Corbetta; Gaspare Galati, Ph.D., associate professor of psychology at the University of Rome; and Gian Luca Romani, Ph.D., professor of physics at the University of Chieti. To help distinguish between the influx of sensory information and the decision to move the eye or hand, subjects had to wait for 10 seconds after seeing the image before indicating which type it was.

Scientists concentrated on regions of the brain that are responsible for planning actions (eye or hand movements) in the parietal lobe. Activity in these different regions would increase in correspondence with the type of stimulus a subject was being shown (face or building) and the type of response they were planning as a result (eye or hand movement). When the stimulus had less noise and subjects were more confident in their choice, brain activity levels in the appropriate area rose proportionally. In addition, these regions showed activity that related to the choice even when the stimulus was ambiguous.

"This suggests that these regions in the parietal lobe processed all the sensory, decision and motor signals necessary to make and act on the decision," Tosoni says. "In contrast, no area in the frontal lobe, thought to be involved in decision-making, significantly increased its activity at the time of decision."

The training period that preceded the scans could have involved the frontal lobes,
'/>"/>

Contact: Michael C. Purdy
purdym@wustl.edu
314-286-0122
Washington University School of Medicine
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. GP targets on heart disease should be simpler and based more on treatment and prevention
2. If you think cancer genes are simple, you dont know JAK
3. Safer, Simpler, Better & Cost Effective Cosmetic Surgery Anesthesia
4. Simple, personalized interventions improve colorectal cancer screening rates
5. AUDIO from Medialink and Bayer: Simple, Focused Ways to Boost Womens Health
6. Simplex Diabetic Supply, Inc. Secures $50 Million in Growth Equity from New Enterprise Associates
7. Simpler Anemia Treatment May Help Kidney Patients
8. Six Simple Steps to Protect Against and Stop the Spread of Superbugs
9. LA BioMed research finds simpler way to assess breast cancer risk
10. Simple Tips Keep the Flu at Bay
11. YMCA of the USA Offers Simple Tips to Give the Lifetime Gift of Health and Well-Being to Family and Friends This Holiday Season
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Torchmark Corporation Declares Dividend 2Health News:America's Pending Shortage of Cancer Doctors 2Health News:America's Pending Shortage of Cancer Doctors 3Health News:Preeclampsia Might Protect Against Testicular Cancer 2Health News:Preeclampsia Might Protect Against Testicular Cancer 3Health News:New Online Support Site Offers Hope, Information, and Help for Patients Who Have Suffered a Catastrophic Injury 2Health News:Media Affects Public Perception of Infectious Diseases 2Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 2Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 3Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 4Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 5Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 6Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 7Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 8Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 9Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 10Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 11Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 12Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 13Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 14Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 15Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 16Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 17Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 18Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 19Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 20Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 21Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 22Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 23Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 24Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 25Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 26Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 27Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 28Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 29
Breaking Medicine Technology:ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4VidaySalud.com(TM) Reaches 1,000,000 Page Views In its First Six Months of Operation 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Qforma Appoints Erin McLaughlin as Director Field Operations 5834 1Qforma Appoints Erin McLaughlin as Director Field Operations 5834 2Webcast Alert 3A Transgenomic Inc Announces Third Quarter 2009 Earnings Release Conference Call Webcast 5832 1Webcast Alert 3A Transgenomic Inc Announces Third Quarter 2009 Earnings Release Conference Call Webcast 5832 2High Resolution Breast PET Improves Breast Cancer Detection 5830 1High Resolution Breast PET Improves Breast Cancer Detection 5830 2High Resolution Breast PET Improves Breast Cancer Detection 5830 3